DOCSLIB.ORG

Update Tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Update Tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14 Update tot 28-05-2020 1. COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. 2. COVID-19, Australia: Epidemiology Report 15 (Reporting week to 23:59 AEST 10 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.43. 3. Erratum: COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020). Communicable diseases intelligence (2018). 2020;44. http://dx.doi.org/10.33321/cdi.2020.44.44. 4. Metformin and COVID-19: A novel deal of an Old Drug. A.A ELA, Abdalla M. Journal of Medical Virology. 2020. 5. The mutual effects of COVID-19 and obesity. Abbas AM, Fathy SK, Fawzy AT, Salem AS, Shawky MS. Obesity Medicine. 2020;19. 6. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review. Aboughdir M, Kirwin T, Abdul Khader A, Wang B. Viruses. 2020;12(5). 7. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients. Abrishami A, Samavat S, Behnam B, Arab-Ahmadi M, Nafar M, Sanei Taheri M. European Urology. 2020. 8. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. Addeo A, Obeid M, Friedlaender A. J Immunother Cancer. 2020;8(1). http://dx.doi.org/10.1136/jitc-2020-000892. 9. 5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection. Ahmad SI. Med Hypotheses. 2020;142:109754. http://dx.doi.org/10.1016/j.mehy.2020.109754. 10. The accuracy of “Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data”. Ahmadi A, Kheiril S, Mohammadian-Hafshejani A, Raeisi H, Mosavi M, Sharifi H. International Journal of Infectious Diseases. 2020;95:319-20. 11. Pharmacological options in treating SARS-CoV-2 infection/COVID-19. Ákos F, István L, Marianna J, Mariann B, Tamás V, György K, et al. Orvosi Hetilap. 2020;161(17):685-8. 12. Turkish Cardiology Association Consensus Report: COVID-19 Pandemic and Cardiovascular Diseases (May 13, 2020). Aktoz M, Altay H, Aslanger E, Atalar E, Atar İ, Aytekin V, et al. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2020;48:1-87. 13. A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection. Alberici F, Delbarba E, Manenti C, Econimo L, Valerio F, Pola A, et al. Kidney international. 2020. http://dx.doi.org/10.1016/j.kint.2020.04.030. 14. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Albini A, Di Guardo G, Noonan DM, Lombardo M. Internal and emergency medicine. 2020. http://dx.doi.org/10.1007/s11739-020-02364-6. 15. Guidelines for dental care provision during the COVID-19 pandemic. Alharbi A, Alharbi S, Alqaidi S. Saudi Dental Journal. 2020;32(4):181-6. 16. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. PLoS ONE. 2020;15(5). 17. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide? Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Travel Medicine and Infectious Disease. 2020. 18. Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19. Amasamy R, Milne KM, Stoneham SM, Chevassut TJ. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16869. 19. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Amawi H, Abu Deiab GI, Aa AA, Dua K, Tambuwala MM. Therapeutic delivery. 2020;11(4):245-68. http://dx.doi.org/10.4155/tde-2020-0035. Epub 2020 May 12. 20. Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection. Ameratunga R, Lehnert K, Leung E, Comoletti D, Snell R, Woon ST, et al. The New Zealand medical journal. 2020;133(1515):112-8. 21. What does the COVID-19 pandemic mean for HIV, tuberculosis, and malaria control? Amimo F, Lambert B, Magit A. Tropical medicine and health. 2020;48:32. http://dx.doi.org/10.1186/s41182-020-00219-6. eCollection 2020. 22. Recommendations for the management of patients with immune-mediated kidney disease during the severe acute respiratory syndrome coronavirus 2 pandemic. Anders HJ, Bruchfeld A, Fernandez Juarez GM, Floege J, Goumenos D, Turkmen K, et al. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020. http://dx.doi.org/10.1093/ndt/gfaa112. 23. Chilblains in children in the setting of COVID-19 pandemic. Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, et al. Pediatric dermatology. 2020. 24. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study. Angelo Vaira L, Hopkins C, Salzano G, Petrocelli M, Melis A, Cucurullo M, et al. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26269. 25. Does communicable diseases (including COVID-19) may increase global poverty risk? A cloud on the horizon. Anser MK, Yousaf Z, Khan MA, Nassani AA, Alotaibi SM, Qazi Abro MM, et al. Environmental Research. 2020;187. 26. COVID-19: a novel coronavirus and a novel challenge for critical care. Arabi YM, Murthy S, Webb S. Intensive Care Medicine. 2020;46(5):833-6. 27. Mapping the incidence of the COVID-19 hotspot in Iran – Implications for Travellers. Arab-Mazar Z, Sah R, Rabaan AA, Dhama K, Rodriguez-Morales AJ. Travel Medicine and Infectious Disease. 2020;34. 28. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. JAMA - Journal of the American Medical Association. 2020;323(16):1612-4. 29. Anticipating the “Second Wave” of Health Care Strain in the COVID-19 Pandemic. Argulian E. JACC: Case Reports. 2020;2(5):845-6. 30. Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients. Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, et al. Br J Haematol. 2020. http://dx.doi.org/10.1111/bjh.16852. 31. Insights from immuno-oncology: The Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19. Ascierto PA, Fox B, Urba W, Anderson AC, Atkins MB, Borden EC, et al. Journal for ImmunoTherapy of Cancer. 2020;8(1). 32. Management of patients with COPD during the COVID-19 pandemic. Attaway A. Cleveland Clinic journal of medicine. 2020. 33. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. The FEBS journal. 2020. http://dx.doi.org/10.1111/febs.15375. 34. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California. Azar KMJ, Shen Z, Romanelli RJ, Lockhart SH, Smits K, Robinson S, et al. Health affairs (Project Hope). 2020:101377hlthaff202000598. http://dx.doi.org/10.1377/hlthaff.2020.00598. 35. Telehealth for High-Risk Pregnancies in the Setting of the COVID-19 Pandemic. Aziz A, Zork N, Aubey JJ, Baptiste CD, D'Alton ME, Emeruwa UN, et al. American journal of perinatology. 2020. 36. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Allergy. 2020. 37. A Chinese case of coronavirus disease 2019 (COVID-19) did not show infectivity during the incubation period: Based on an epidemiological survey. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):67-9. 38. Author response: Coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. Bae JM. Journal of Preventive Medicine and Public Health. 2020;53(2):71. 39. What dentists need to know about COVID-19. Baghizadeh Fini M. Oral Oncology. 2020;105. 40. Covid-19 management: It's inappropriate to make judgments in hindsight that rely on information not available at the outset. Bamji AN. The BMJ. 2020;369. 41. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. Banerjee A, Pasea L, Harris S, Gonzalez-Izquierdo A, Torralbo A, Shallcross L, et al. Lancet (London, England). 2020. 42. ‘Age and ageism in COVID-19’: Elderly mental health-care vulnerabilities and needs. Banerjee D. Asian Journal of Psychiatry. 2020;51. 43. COVID-19 Worries and Behavior Changes in Older and Younger Men and Women. Barber SJ, Kim H. The journals of gerontology Series B, Psychological sciences and social sciences. 2020. http://dx.doi.org/10.1093/geronb/gbaa068. 44. Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice. Barra S, Guarnieri A, di Monale EBMB, Marcenaro M, Tornari E, Belgioia L, et al. La Radiologia medica. 2020. http://dx.doi.org/10.1007/s11547-020-01216-9. 45. Covid-19 and infection in health-care workers: An emerging problem. Barranco R, Ventura F. The Medico-legal journal. 2020:25817220923694. http://dx.doi.org/10.1177/0025817220923694. 46. A Proposed Plan for Prenatal Care to Minimize Risks of COVID-19 to Patients and Providers: Focus on Hypertensive Disorders of Pregnancy.
Load more

Recommended publications
  • PROTESTS and REGIME SUPPRESSION in POST-REVOLUTIONARY IRAN Saeid Golkar
    THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY n OCTOBER 2020 n PN85 PROTESTS AND REGIME SUPPRESSION IN POST-REVOLUTIONARY IRAN Saeid Golkar Green Movement members tangle with Basij and police forces, 2009. he nationwide protests that engulfed Iran in late 2019 were ostensibly a response to a 50 percent gasoline price hike enacted by the administration of President Hassan Rouhani.1 But in little time, complaints Textended to a broader critique of the leadership. Moreover, beyond the specific reasons for the protests, they appeared to reveal a deeper reality about Iran, both before and since the 1979 emergence of the Islamic Republic: its character as an inherently “revolutionary country” and a “movement society.”2 Since its formation, the Islamic Republic has seen multiple cycles of protest and revolt, ranging from ethnic movements in the early 1980s to urban riots in the early 1990s, student unrest spanning 1999–2003, the Green Movement response to the 2009 election, and upheaval in December 2017–January 2018. The last of these instances, like the current round, began with a focus on economic dissatisfaction and then spread to broader issues. All these movements were put down by the regime with characteristic brutality. © 2020 THE WASHINGTON INSTITUTE FOR NEAR EAST POLICY. ALL RIGHTS RESERVED. SAEID GOLKAR In tracking and comparing protest dynamics and market deregulation, currency devaluation, and the regime responses since 1979, this study reveals that cutting of subsidies. These policies, however, spurred unrest has become more significant in scale, as well massive inflation, greater inequality, and a spate of as more secularized and violent.
    [Show full text]
  • AMERICA in the FACE of the STORM أمريكا في وجه العاصفة !! العربي األمريكي اليوم Arab American Today
    مارس 2020 م - السنة الثامنة - العدد: March 2020 - Volume : 8 - Issue :87 87 ترامب يعاند الخبراء الصحيين ويتعامل بعقلية التاجر مع كورونا Survey reveals Yemen war’s ‘devastating impact’ on child mental health اليمن يستعد لمواجهة كورونا بنظام صحي هش World Bank could deploy $150 billion over 15 months in coronavirus battle زعماء مجموعة العشرين يتعهدون بجبهة موحدة ضد كورونا “Contigen” film predicted outbreaks of Corona virus 10 years ago دراسة »متفائلة« حول فيروس كورونا الجديد AMERICA IN THE FACE OF THE STORM أمريكا في وجه العاصفة !! العربي اﻷمريكي اليوم Arab American Today EVERY PERSON In Michigan Deserves Access To Good HEALTHCARE To fund life-saving programs like MIChild, urgent care, Medicaid and Medicare YOU and YOUR FAMILY must be counted in the 2020 CENSUS this spring. The 2020 CENSUS Is quick and EASY to fi ll out. Use it to count EVERYONE in your home. And by law, it is 100% CONFIDENTIAL For more information go to www.mivoicecounts.org 002 مارس 2020 م - السنة الثامنة - العدد: WWW.ARABAMERICANTODAY.NET 87 العربي اﻷمريكي اليوم Arab American Today مع تحيات مجلة العربي اﻷمريكي اليوم 003 March 2020 - Volume : 8 - Issue :87 WWW.ARABAMERICANTODAY.NET نصوص Provision العربي اﻷمريكي اليوم Arab American Today زهرة التوليب نصف سماء كئيبة عبد الجواد العوفير* وجه إيديت عمر الشيخ * الواقع. ُسقت ثروات تلك الشعوب، ِحوربت الشتاء يطرق الباب ثقافتهم، ثم جاء فنّان ّمدع ليستبيح حقّهم يف ٍ ٍبمعطف حزين تقرير مصري صغري، أ ّﻻ تُستغلَّ مﻻمحهم. قضيت عمرا ًبالنظر إىل حياتكم، دعوتها » للجلوس هنا، عىل كأس، فهل أفتح القلب ُسقت ثرواتهم ثم جاء فنّان ّمدع ليستبيح حقّهم رميت لها كل الحلوى ﻷجذب هوسها كي يدخل الحب؟ يف تقرير ٍمصري صغري بالجمال، لكن املرارات التي سنقولها » كانت أثقل من كحول العالم..
    [Show full text]
  • Supplement RAND Appropriateness Panel to Determine The
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) Thorax Supplement RAND appropriateness panel to determine the applicability of UK guidelines on the management of acute respiratory distress syndrome (ARDS) and other strategies in the context of the COVID-19 pandemic ǂ*Mark JD Griffiths FRCP1,2,3, *Susanna Meade MB ChB 4, *Charlotte Summers PhD5, *Danny F McAuley MD6, *Alastair G Proudfoot FRCP1,3,8, Marta Montero Baladia9, Paul Dark PhD10, Kate Diomede MB ChB11 Simon J. Finney FRCA1,3, Lui G Forni PhD12, Christopher Meadows FRCP 4, Ian A Naldrett MSc13,14, Brijesh V. Patel FFICM14,15 Gavin D. Perkins MD16, Mark A Samaan MB BS4, Laurence Sharifi FRCA9, Ganesh Suntharalingam FRCA17,18, Nicholas T Tarmey FFICM19, Matt P Wise DPhil20, Harriet F Young MRCP1, Peter M Irving MD4,7 1 Barts Heart Centre, St Bartholomew’s Hospital, London, UK. 2 National Heart & Lung Institute, Imperial College London, London, UK. 3 William Harvey Research Institute, Queen Mary University of London, London, UK. 4 Guy’s and St Thomas’ NHS Foundation Trust, London, UK. 5 Department of Medicine, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 6 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Science, Queen’s University Belfast and Regional Intensive Care Unit, Royal Victoria Hospital, Belfast UK. 7 School of Immunology and Microbial Sciences, King's College London, UK. 8 Nightingale Hospital, London, UK. 9 Barts & The London School of Anaesthesia, The Royal London Hospital, Whitechapel, London, E1 1BB, UK.
    [Show full text]
  • COVID-19 Publications - Week 17 2021 1448 Publications
    Update April 26 - May 02, 2021, Dr. Peter J. Lansberg MD, PhD Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics COVID-19 publications - Week 17 2021 1448 Publications PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected] Reliable on-line resources for Covid 19 WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap) Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known
    [Show full text]
  • The Coronavirus Outbreak in Iran: Political and Economic Implications
    INFO PACK The Coronavirus Outbreak in Iran: Political and Economic Implications INFO PACK The Coronavirus Outbreak in Iran: Political and Economic Implications The Coronavirus Outbreak in Iran: Political and Economic Implications © TRT WORLD RESEARCH CENTRE ALL RIGHTS RESERVED PUBLISHER TRT WORLD RESEARCH CENTRE March 2020 WRITTEN BY Merve Akın PHOTO CREDIT ANADOLU AGENCY TRT WORLD İSTANBUL AHMET ADNAN SAYGUN STREET NO:83 34347 ULUS, BEŞİKTAŞ İSTANBUL / TURKEY TRT WORLD LONDON 200 GRAYS INN ROAD, WC1X 8XZ LONDON / UNITED KINGDOM TRT WORLD WASHINGTON D.C. 1819 L STREET NW SUITE, 700 20036 WASHINGTON DC / UNITED STATES www.trtworld.com researchcentre.trtworld.com The opinions expressed in this Info Pack represent the views of the author(s) and do not necessarily reflect the views of the TRT World Research Centre. 4 The Coronavirus Outbreak in Iran: Political and Economic Implications Introduction n December 2019, China alerted the World the death and infection rate has increased severely. Health Organization (WHO) to 3l cases of an Iranian Deputy Health Minister Iraj Harirchi claims unknown virus in the city of Wuhan. By ear- that COVID-19 infects 43 Iranians and takes 3 lives ly January the situation was starting to get per hour. For its part, the WHO has asserted that the out of control and on January 7th, Chinese death toll could be potentially five times higher. Iofficials announced that they had identified a new virus, later named COVID-19 by the WHO, which Economic difficulties resulting from US sanctions belongs to the coronavirus family. The quick spread make Iran’s struggle with the coronavirus even more of the virus has created a global emergency, as con- difficult.
    [Show full text]
  • Saudi-Led G20 Summit Marks Global Turning Point in Tackling Pandemic
    UK £2 Issue 250, Year 5 March 29, 2020 EU €2.50 www.thearabweekly.com Turkish military Salafists’ Abu Dhabi crown industry buttresses opportunistic prince’s solidarity ambitions overreach towards Syria Page 16 Page 13 Page 3 Saudi-led G20 summit marks global turning point in tackling pandemic fallout Serious questions and a lot of work remain ahead for the G20 in its stewardship of the global economy. Sabahat Khan gether and cooperate in order to face this challenge.” Prospects for a coordinated world- Dubai wide health response and economic support had been marred by divi- he first virtual Group of 20 sions between the United States and summit, presided over by China over responsibility for the pan- Saudi King Salman bin Ab- demic. T dulaziz Al Saud, set the track At the end of the meeting, G20 for a global approach to tackle the leaders released a communique tell- worldwide fallout from the spread- ing the world they are prepared to do ing coronavirus pandemic but many whatever it takes to overcome coro- short- and long-term questions re- navirus pandemic. main. The G20 announced plans to inject Saudi Arabia, which assumed the $5 trillion into the global economy rotating presidency of the G20 this to preserve financial stability and year, called an extraordinary meet- revive growth by restoring confi- ing of the group and organised it in dence. The World Bank is finalising less than a week. a relief package of up to $160 billion International summits typically of its own while the United Kingdom take months of preparation — the committed $253 million towards the G20’s annual summit is scheduled international effort for finding a vac- for November in Riyadh — but the cine for coronavirus.
    [Show full text]
  • Ebola, Lassa Fever, Corona Virus (Covid-19) Pandemic Etc Respectively Curable Or Suppress Able?
    Available Online at http://www.recentscientific.com International Journal of CODEN: IJRSFP (USA) Recent Scientific International Journal of Recent Scientific Research Research Vol. 11, Issue, 07 (C), pp. 39305-39329, July, 2020 ISSN: 0976-3031 DOI: 10.24327/IJRSR Research Article DOES HIV/AID/ SEVERE ACUTE RESPIRATORY SYNDROME (SARS), EBOLA, LASSA FEVER, CORONA VIRUS (COVID-19) PANDEMIC ETC RESPECTIVELY CURABLE OR SUPPRESS ABLE? Silas David Emmanuel1*, Barminas Jeffrey Tsware2, I.M.Bugaje, 3R, A .Damau and 4E.N. OPARA5 1,2Kaduna Polytechnic Tudun Wada Kaduna State, Nigeria 3,4National Research Institute of Chemical and Technology (NARICT), Basawa Zaria, Nigeria 5Nigerian Institute of Leather and Science Technology (NILEST), Samaru Zaria DOI: http://dx.doi.org/10.24327/ijrsr.2020.1107.5477 ARTICLE INFO ABSTRACT Article History: The unprecedented corona virus disease (COVID-19) has been duly identified as the cause of outbreaks of respiratory illness in Wuhan, Hubei province China at the beginning of December 2019 Received 6th April, 2020 th and up to date. In our case study, the general over view of the confirm cases, recovered, and death Received in revised form 15 toll were in these orders3,037605, 82959,210,842 respectively. The world Health Organization May, 2020 (WHO) has duly declared it a public Health emergency of international repute or concern. The Accepted 12th June, 2020 th method employed was primarilybased on the literaturereview approach, which was largely and Published online 28 July, 2020 qualitatively in nature and guided by scheme emerging infectious diseases by viral pandemic (Covid-19, SARS-Cov2) etc respectively. In view of our findings it was recorded USA has the Key Words: highest Covid-19 confirm cases, recovered and death toll with 987467, 111197, Coronavirus; COVID-19; SARS-CoV- 56,164respectively, followed by Spain with 209465, 232,128, 23,822respectively, Germany, Italy, 2;severe acute respiratory syndrome china have their own set back with 158,768, 117,400 ,6,136 / Italy with 192, 414, 66,624, 26977,82,862, 27610, 4,633 respectively.
    [Show full text]
  • Downloaded from the Think Tank Webpage
    CENTRO STUDI PER I POPOLI EXTRA-EUROPEI “CESARE BONACOSSA” - UNIVERSITÀ DI PAVIA ASIA MAIOR The Journal of the Italian think tank on Asia founded by Giorgio Borsa in 1989 Vol. XXXI / 2020 Asia in 2020: Coping with COVID-19 and other crises Edited by Michelguglielmo Torri Nicola Mocci Filippo Boni viella Asia Maior. The Journal of the Italian Think Tank on Asia founded by Giorgio Borsa in 1989. Copyright © 2021 - Viella s.r.l. & Associazione Asia Maior ISBN 978-88-3313-827-5 (Paper) ISBN 978-88-3313-828-2 (Online) ISSN 2385-2526 (Paper) ISSN 2612-6680 (Online) Annual journal - Vol. XXXI, 2020 This journal is published jointly by the think tank Asia Maior (Associazione Asia Maior) & the CSPE - Centro Studi per i Popoli extra-europei «Cesare Bonacossa», University of Pavia Asia Maior. The Journal of the Italian Think Tank on Asia founded by Giorgio Borsa in 1989 is an open-access journal, whose issues and single articles can be freely downloaded from the think tank webpage: www.asiamaior.org. The reference year is the one on which the analyses of the volume are fo- cused. Each Asia Maior volume is always published in the year following the one indicated on the cover. Paper version Italy € 50.00 Abroad € 65.00 Subscription [email protected] www.viella.it EDITORIAL BOARD Editor-in-chief (direttore responsabile): Michelguglielmo Torri, University of Turin. Co-editors: Nicola Mocci, University of Florence. Filippo Boni, The Open University. Associate editors: Axel Berkofsky, University of Pavia; Diego Maiorano, National University of Singapore, ISAS - Institute of South Asian Studies; Giulio Pugliese, King’s College London; Emanuela Mangiarotti, University of Pavia; Pierluigi Valsecchi, University of Pavia.
    [Show full text]